Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmastectomy Hypofractionated Versus Conventional Fractionated Radiotherapy in High Risk Breast Cancer: a Phase III Randomized Clinical Trial

NCT03856372 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03856372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03856372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmastectomy Hypofractionated Versus Conventional Fractionated Radiotherapy in High Risk Breast Cancer: a Phase III Randomized Clinical Trial
Lead sponsor
Fudan University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2018
Completion date
August 30, 2022
Enrollment
1,494 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer